Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T28520 |
Retagliptin
SP-2086,SP2086,SP 2086 |
||
Retagliptin is a DPP-4 inhibitor potentially used to treat Type 2 diabetes. | |||
T12710 |
Retagliptin Phosphate
SP 2086,瑞格列汀磷酸盐 |
Proteasome; DPP-4 | Proteases/Proteasome; Ubiquitination |
Retagliptin Phosphate (SP 2086) 是一种选择性、竞争性、口服活性的二肽基肽酶 4 (DPP-4) 抑制剂。Retagliptin phosphate 能够用于 2 型糖尿病 (T2DM) 的研究。 |